REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study

Clinical trial NCT00485069 · COMPLETED

Trial details

NCT number: NCT00485069
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Parkinson Disease Parkinson's Disease

Start date: 2007-06-01
Primary completion: 2009-12-01
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.